Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06466655 · ClinicalTrials.gov registry record · NA
Daily Stress and Vascular Function in Midlife as a Risk Factor for Cognitive Decline
A NA study, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT06466655 is a NA study that has completed, run by University of Delaware. The registered enrollment target is 17 participants.
The verdict
NCT06466655, a NA study, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The goal of this pilot clinical trial is to begin to understand how day-to-day stress affects cardiovascular health and brain function in middle-aged adults. The main question aims to answer is whether the link between daily stress and vascular dysfunction is a potential mechanism of increased risk for future cognitive decline. Participants will complete a 15-day testing cycle. During this cycle, participants will complete daily assessments of stress using an online survey tool for 14-consecutive days. On the last day of each cycle, vascular function will be assessed during a laboratory visit.
Interventions
- DRUG MitoTempol
- DRUG Lactated Ringer's (control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2024-05-30 |
| Est. Completion | 2025-05-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06466655
The ClinicalTrials.gov registry entry for NCT06466655 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MitoTempol is the first listed.
NCT06466655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06466655 about?
NCT06466655 is a clinical study titled "Daily Stress and Vascular Function in Midlife as a Risk Factor for Cognitive Decline". The goal of this pilot clinical trial is to begin to understand how day-to-day stress affects cardiovascular health and brain function in middle-aged adults. The main question aims to answer is whether the link between daily stress and vascular dysfunction is a potential mechanism of increased risk ...
What is the current status of trial NCT06466655?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2024-05-30. Estimated completion is 2025-05-29.
What interventions are being tested in trial NCT06466655?
The interventions under investigation include: MitoTempol (DRUG), Lactated Ringer's (control) (DRUG).
Who is sponsoring clinical trial NCT06466655?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.